NasdaqCM - Delayed Quote USD
Viridian Therapeutics, Inc. (VRDN)
13.57
-0.10
(-0.73%)
At close: May 23 at 4:00:00 PM EDT
13.02
-0.55
(-4.05%)
After hours: May 23 at 5:20:04 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BEETHAM THOMAS W Chief Operating Officer | Purchase | Sep 27, 2024 | 6,000 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 13, 2024 | -- |
| MAHONEY STEPHEN F Chief Executive Officer | Purchase | Sep 27, 2024 | 21,400 |
| MEISNER LARA Officer | Sale | Jun 16, 2023 | 29,971 |
Related Tickers
TRML Tourmaline Bio, Inc.
15.32
+0.33%
ORKA Oruka Therapeutics, Inc.
10.95
-2.14%
BCAX Bicara Therapeutics Inc.
9.27
-40.80%
EWTX Edgewise Therapeutics, Inc.
14.21
+1.36%
MRUS Merus N.V.
55.14
+32.55%
TRVI Trevi Therapeutics, Inc.
6.29
+4.31%
ORIC ORIC Pharmaceuticals, Inc.
6.35
+6.72%
MLYS Mineralys Therapeutics, Inc.
15.96
-2.21%
GYRE Gyre Therapeutics, Inc.
8.68
-22.57%
APGE Apogee Therapeutics, Inc.
39.48
-2.18%